Literature DB >> 15720240

Behçet's disease as an autoinflammatory disorder.

Ahmet Gül1.   

Abstract

Autoinflammatory diseases are a group of heritable disorders that are characterized by seemingly unprovoked episodes of inflammation at certain locations and and relative lack of high-titer autoantibodies or antigen-specific T cells. Behçet's disease is an inflammatory disorder of unknown aetiology, and many of its characteristic recurrent manifestations overlap with those of autoinflammatory diseases. Behçet's disease has a complex genetic aetiology, and it is more prevalent in certain geographic regions and/or in particular ethnic groups. Enhanced inflammatory response and over-expression of proinflammatory cytokines are the prominent features of Behçet's disease, and they are compatible with the findings in other autoinflammatory disorders. There are also evidences of antigen-driven immune response in Behçet's disease, but it possibly develops on the background of enhanced innate immune reactivity. Delineation of the similarities of Behçet's disease to other hereditary autoinflammatory diseases may help to clarify its pathogenesis and also to identify the missing links in the shared inflammatory pathways.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15720240     DOI: 10.2174/1568010053622894

Source DB:  PubMed          Journal:  Curr Drug Targets Inflamm Allergy        ISSN: 1568-010X


  73 in total

Review 1.  Interplay between innate and adaptive immunity in the development of non-infectious uveitis.

Authors:  François Willermain; James T Rosenbaum; Bahram Bodaghi; Holly L Rosenzweig; Sarah Childers; Travis Behrend; Gerhild Wildner; Andrew D Dick
Journal:  Prog Retin Eye Res       Date:  2011-11-22       Impact factor: 21.198

Review 2.  Behçet syndrome: is it one condition?

Authors:  H Yazici; S Ugurlu; E Seyahi
Journal:  Clin Rev Allergy Immunol       Date:  2012-12       Impact factor: 8.667

Review 3.  Behçet's syndrome.

Authors:  Yusuf Yazici; Sebahattin Yurdakul; Hasan Yazici
Journal:  Curr Rheumatol Rep       Date:  2010-12       Impact factor: 4.592

4.  PFAPA syndrome and Behçet's disease: a comparison of two medical entities based on the clinical interviews performed by three different specialists.

Authors:  Luca Cantarini; Antonio Vitale; Giulia Bersani; Laura Martin Nieves; Marco Cattalini; Giuseppe Lopalco; Francesco Caso; Luisa Costa; Florenzo Iannone; Giovanni Lapadula; Mauro Galeazzi; Angela Ceribelli; Enrico Brunetta; Carlo Selmi; Donato Rigante
Journal:  Clin Rheumatol       Date:  2015-02-10       Impact factor: 2.980

5.  Immune and inflammatory gene expressions are different in Behçet's disease compared to those in Familial Mediterranean Fever.

Authors:  Filiz Türe Özdemir; Emel Ekşioğlu Demiralp; Sibel Z Aydın; Pamir Atagündüz; Tülin Ergun; Haner Direskeneli
Journal:  Eur J Rheumatol       Date:  2016-12-01

Review 6.  Standard and novel therapeutic approaches to Behçet's disease.

Authors:  Ahmet Gul
Journal:  Drugs       Date:  2007       Impact factor: 9.546

7.  Anti-IL-1 treatment for secondary amyloidosis in an adolescent with FMF and Behçet's disease.

Authors:  Yelda Bilginer; Nuray Aktay Ayaz; Seza Ozen
Journal:  Clin Rheumatol       Date:  2009-09-23       Impact factor: 2.980

8.  TNF-alpha gene polymorphisms in Iranian Azeri Turkish patients with Behcet's Disease.

Authors:  Mortaza Bonyadi; Zohreh Jahanafrooz; Mohsen Esmaeili; Susan Kolahi; Alireza Khabazi; Ali Asghar Ebrahimi; Mehrzad Hajialilo; Saeed Dastgiri
Journal:  Rheumatol Int       Date:  2009-09-23       Impact factor: 2.631

Review 9.  Optic neuritis as a presenting feature of Behçet's disease: case-based review.

Authors:  Željka Kardum; Jasminka Milas Ahić; Ana Marija Lukinac; Ružica Ivelj; Višnja Prus
Journal:  Rheumatol Int       Date:  2020-08-29       Impact factor: 2.631

10.  Transient involvement of the cerebral cortex in a flare of Behçet's syndrome.

Authors:  Walter Conca; Soliman A Kamel; Dominic Venne; Peter Corr
Journal:  Rheumatol Int       Date:  2010-01-07       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.